Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Old wine in new bottles: Drug repurposing in oncology.

Antoszczak M, Markowska A, Markowska J, Huczyński A.

Eur J Pharmacol. 2020 Jan 5;866:172784. doi: 10.1016/j.ejphar.2019.172784. Epub 2019 Nov 12. Review.

PMID:
31730760
2.

Correction to: Methods for 20S Immunoproteasome and 20S Constitutive Proteasome Determination Based on SPRI Biosensors.

Sankiewicz A, Markowska A, Lukaszewski Z, Puzan B, Gorodkiewicz E.

Cell Mol Bioeng. 2018 Oct 19;12(1):133. doi: 10.1007/s12195-018-00559-8. eCollection 2019 Feb.

3.

The role of nesfatin and selected molecular factors in various types of endometrial cancer.

Markowska A, Szarszewska M, Knapp P, Grybos A, Grybos M, Marszalek A, Filas V, Wojcik-Krowiranda K, Swornik M, Markowska J.

Ginekol Pol. 2019;90(10):571-576. doi: 10.5603/GP.2019.0099.

4.

The Effects of a Novel Series of KTTKS Analogues on Cytotoxicity and Proteolytic Activity.

Tałałaj U, Uścinowicz P, Bruzgo I, Surażyński A, Zaręba I, Markowska A.

Molecules. 2019 Oct 15;24(20). pii: E3698. doi: 10.3390/molecules24203698.

5.

Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs.

Markowska A, Kaysiewicz J, Markowska J, Huczyński A.

Bioorg Med Chem Lett. 2019 Jul 1;29(13):1549-1554. doi: 10.1016/j.bmcl.2019.04.045. Epub 2019 Apr 27. Review.

PMID:
31054863
6.

Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis - A multicentre study.

Szarszewska M, Markowska A, Jach R, Marszałek A, Filas V, Bednarek W, Olejek A, Tomczak P, Sajdak S, Nowak-Markwitz E, Jaszczyńska-Nowinka K, Stanisławiak-Rudowicz J, Gryboś A, Chudecka-Głaz A, Gryboś M, Adamska K, Ramlau R, Markowska J, Knapp P.

Adv Med Sci. 2019 Sep;64(2):235-240. doi: 10.1016/j.advms.2018.12.007. Epub 2019 Feb 26.

PMID:
30822630
7.

Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations.

Basta T, Knapp P, Blecharz P, Bodnar L, Gawron I, Babczyk D, Piróg M, Kluz T, Markowska A, Horbaczewska A, Jach R.

PLoS One. 2019 Jan 31;14(1):e0209901. doi: 10.1371/journal.pone.0209901. eCollection 2019.

8.

Studies on selected molecular factors in endometrial cancers.

Markowska A, Szarszewska M, Żurawski J, Sajdak S, Knapp P, Gryboś A, Olejek A, Bednarek W, Roszak A, Jóźwik M, Marszałek A, Filas V, Wójcik-Krowiranda K, Mądry R, Markowska J, Sozański R.

Adv Clin Exp Med. 2018 Oct;27(10):1417-1424. doi: 10.17219/acem/70861.

9.

Ovarian cancer stem cells: A target for oncological therapy.

Markowska A, Sajdak S, Huczyński A, Rehlis S, Markowska J.

Adv Clin Exp Med. 2018 Jul;27(7):1017-1020. doi: 10.17219/acem/73999. Review.

10.

Verbal fluency in research conducted with PET technique under conditions of extended cognitive activation with the use of 18F-fluorodeoxyglucose (FDG) tracer.

Zając-Lamparska L, Wiłkość M, Markowska A, Laskowska-Levy IP, Wróbel M, Małkowski B.

Psychiatr Pol. 2017 Aug 29;51(4):687-703. doi: 10.12740/PP/OnlineFirst/62394. Epub 2017 Aug 29. English, Polish.

11.

A novel method for the isolation of extracellular vesicles and RNA from urine.

Markowska A, Pendergrast RS, Pendergrast JS, Pendergrast PS.

J Circ Biomark. 2017 Jun 12;6:1849454417712666. doi: 10.1177/1849454417712666. eCollection 2017 Jan-Dec.

12.

The Possible Pre- and Post-UVA Radiation Protective Effect of Amaranth Oil on Human Skin Fibroblast Cells.

Wolosik K, Zareba I, Surazynski A, Markowska A.

Pharmacogn Mag. 2017 Jul;13(Suppl 2):S339-S343. doi: 10.4103/pm.pm_522_15. Epub 2017 Jul 11.

13.

Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer.

Markowska A, Sajdak S, Markowska J, Huczyński A.

Eur J Med Chem. 2017 Dec 15;142:87-94. doi: 10.1016/j.ejmech.2017.06.030. Epub 2017 Jun 20. Review.

PMID:
28651817
14.

Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors.

Purwin M, Markowska A, Bruzgo I, Rusak T, Surażyński A, Jaworowska U, Midura-Nowaczek K.

Int J Pept Res Ther. 2017;23(2):235-245. doi: 10.1007/s10989-016-9555-3. Epub 2016 Sep 19.

16.

Role of cancer stem cells and microRNA in resistance to chemotherapy in patients with ovarian cancer.

Markowska A, Sajdak S.

Eur J Gynaecol Oncol. 2017;38(2):181-183. Review.

PMID:
29953775
17.

Multiple primary cancers in BRCA 1/2 carriers - A review of literature and our observations.

Markowska A, Lubin J, Markowska J, Kasprzak B, Chajewska-Czekańska M, Madry R, Stawicka M.

Eur J Gynaecol Oncol. 2017;38(3):361-363. Review.

PMID:
29693873
18.

The role of overweight and obesity in selected gynecological malignancies.

Markowska A, Stanisławiak-Rudowicz J, Jaszczyńska-Nowinka K.

Eur J Gynaecol Oncol. 2017;38(3):335-341. Review.

PMID:
29693868
19.

Pathophysiological and clinical aspects of gastric hyperplastic polyps.

Markowski AR, Markowska A, Guzinska-Ustymowicz K.

World J Gastroenterol. 2016 Oct 28;22(40):8883-8891. Review.

20.

A Lack of Correlation between Brain-Derived Neurotrophic Factor Serum Level and Verbal Memory Performance in Healthy Polish Population.

Wilkosc M, Markowska A, Zajac-Lamparska L, Skibinska M, Szalkowska A, Araszkiewicz A.

Front Neural Circuits. 2016 May 23;10:39. doi: 10.3389/fncir.2016.00039. eCollection 2016.

21.

Convenient broad-host-range unstable vectors for studying stabilization cassettes in diverse bacteria.

Bartosik AA, Glabski K, Kulinska A, Lewicka E, Godziszewska J, Markowska A, Jagura-Burdzy G.

BMC Microbiol. 2016 Apr 5;16:59. doi: 10.1186/s12866-016-0674-y.

22.

ANTIPROLIFERATIVE EFFECTS ON BREAST CANCER CELLS AND SOME INTERACTIONS OF NEW DISTAMYCIN ANALOGUES WITH DNA, ENDONUCLEASES AND DNA TOPOISOMERASES.

Drozdowska D, Rusak M, Miltyk W, Markowska A, Samczuki P.

Acta Pol Pharm. 2016 Jan-Feb;73(1):47-53.

PMID:
27008800
23.

Oxidative stress markers in uterine fibroids tissue in pre- and postmenopausal women.

Markowska A, Mardas M, Gajdzik E, Zagrodzki P, Markowska J.

Clin Exp Obstet Gynecol. 2015;42(6):725-9.

PMID:
26753472
24.

Morphological and Functional Evaluation of Meibomian Gland Dysfunction in Rosacea Patients.

Machalińska A, Zakrzewska A, Markowska A, Safranow K, Wiszniewska B, Parafiniuk M, Machaliński B.

Curr Eye Res. 2016 Aug;41(8):1029-1034. Epub 2015 Dec 7.

PMID:
26644191
25.

Noble metals in oncology.

Markowska A, Kasprzak B, Jaszczyńska-Nowinka K, Lubin J, Markowska J.

Contemp Oncol (Pozn). 2015;19(4):271-5. doi: 10.5114/wo.2015.54386. Epub 2015 Sep 28. Review.

26.

Late recurrence of ovarian cancer: a literature review and description of two cases.

Iżycka N, Lubin J, Markowska A, Markowska J.

Eur J Gynaecol Oncol. 2015;36(3):351-3. Review.

PMID:
26189270
27.

Evaluation of residual tumor locations in advanced ovarian cancer patients after incomplete primary cytoreduction.

Grabowskil JP, Mardas M, Markowska A, Markowska J.

Eur J Gynaecol Oncol. 2015;36(3):274-7.

PMID:
26189252
28.

Small cell carcinoma of the ovary of the hypercalcemic type (SCCOHT)--case report.

Lubin J, Pawałowska M, Markowska A, Bielas A.

Eur J Gynaecol Oncol. 2015;36(1):88-90.

PMID:
25872342
29.

Signalling pathways in endometrial cancer.

Markowska A, Pawałowska M, Lubin J, Markowska J.

Contemp Oncol (Pozn). 2014;18(3):143-8. doi: 10.5114/wo.2014.43154. Epub 2014 Jun 18. Review.

30.

Evaluation of leptin serum concentrations during surgery and first-line chemotherapy in primary epithelial ovarian cancer patients.

Grabowski JP, Markowska A, Markowska J.

Contemp Oncol (Pozn). 2014;18(5):318-22. doi: 10.5114/wo.2014.46323. Epub 2014 Nov 5.

31.

Antimicrobial peptides and their analogs: searching for new potential therapeutics.

Midura-Nowaczek K, Markowska A.

Perspect Medicin Chem. 2014 Oct 12;6:73-80. doi: 10.4137/PMC.S13215. eCollection 2014.

32.

The Oncology Pain Treatment Clinical Studies Quality Assessment.

Giermaziak W, Faluta T, Bondaryk Z, Markowska A, Deszcz M.

Value Health. 2014 Nov;17(7):A523. doi: 10.1016/j.jval.2014.08.1640. Epub 2014 Oct 26. No abstract available.

33.

Glycobiology of ocular angiogenesis.

Markowska AI, Cao Z, Panjwani N.

Glycobiology. 2014 Dec;24(12):1275-82. doi: 10.1093/glycob/cwu078. Epub 2014 Aug 8. Review.

34.

[Lunasin--a novel chemopreventive peptide].

Wołosik K, Markowska A, Kuźmicz I.

Postepy Biochem. 2014;60(1):84-9. Review. Polish.

PMID:
25033546
35.

Increased concentration of T-cell receptor rearrangement excision circles (TREC) in peripheral blood in Graves' disease.

Strawa K, Markowska A, Miśkiewicz P, Kuś A, Ambroziak U, Szymański K, Zbiec R, Spólnicka M, Krajewski P, Bednarczuk T, Płoski R.

Clin Endocrinol (Oxf). 2014 Nov;81(5):769-74. doi: 10.1111/cen.12492. Epub 2014 Jun 12.

PMID:
24815998
36.

Expression of SDF-1 and CXCR4 transcript variants and CXCR7 in epithelial ovarian cancer.

Jaszczynska-Nowinka K, Rucinski M, Ziolkowska A, Markowska A, Malendowicz LK.

Oncol Lett. 2014 May;7(5):1618-1624. Epub 2014 Feb 20.

37.

Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?

Markowska A, Pawałowska M, Filas V, Korski K, Gryboś M, Sajdak S, Olejek A, Bednarek W, Spiewankiewicz B, Lubin J, Markowska J.

Diabetol Metab Syndr. 2013 Dec 5;5(1):76. doi: 10.1186/1758-5996-5-76.

38.

Effects of dinuclear berenil-platinum(II) complexes on fibroblasts redox status.

Gęgotek A, Markowska A, Łuczaj W, Bielawska A, Bielawski K, Ambrożewicz E, Skrzydlewska E.

Adv Med Sci. 2013;58(2):282-91. doi: 10.2478/ams-2013-0029.

PMID:
24127544
39.

Development of antiangiogenic therapies for ovarian cancer.

Markowska A, Lubin J, Madry R, Markowska J.

Eur J Gynaecol Oncol. 2013;34(4):303-6.

PMID:
24020134
40.

Synthesis and Biological Activity of N-Sulfonyltripeptides with C-Terminal Arginine as Potential Serine Proteases Inhibitors.

Markowska A, Bruzgo M, Gorodkiewicz E, Surażyński A.

Int J Pept Res Ther. 2013;19:191-198. Epub 2012 Dec 2.

41.
42.

Global transcriptional regulator KorC coordinates expression of three backbone modules of the broad-host-range RA3 plasmid from IncU incompatibility group.

Ludwiczak M, Dolowy P, Markowska A, Szarlak J, Kulinska A, Jagura-Burdzy G.

Plasmid. 2013 Jul;70(1):131-45. doi: 10.1016/j.plasmid.2013.03.007. Epub 2013 Apr 11.

PMID:
23583562
43.

Factors affecting response of chemotherapy in women with ovarian cancer.

Lubin J, Markowska A, Knapp P.

Eur J Gynaecol Oncol. 2012;33(6):644-7. Review.

PMID:
23327063
44.

Municipal wastewater treatment in Poland - efficiency, costs and returns to scale.

Berbeka K, Czajkowski M, Markowska A.

Water Sci Technol. 2012;66(2):394-401. doi: 10.2166/wst.2012.199.

PMID:
22699345
45.

Tripeptides with non-code amino acids as potential serine proteases inhibitors.

Markowska A, Bruzgo M, Surażyński A, Midura-Nowaczek K.

J Enzyme Inhib Med Chem. 2013 Jun;28(3):639-43. doi: 10.3109/14756366.2011.651463. Epub 2012 Feb 3.

PMID:
22299583
46.

Determination of counter-ions in synthetic peptides by ion chromatography, capillary isotachophoresis and capillary electrophoresis.

Mrozik W, Markowska A, Guzik L, Kraska B, Kamysz W.

J Pept Sci. 2012 Mar;18(3):192-8. doi: 10.1002/psc.1436. Epub 2012 Jan 17.

PMID:
22252914
47.

The influence of metformin in the etiology of selected cancers.

Pawałowska M, Markowska A.

Contemp Oncol (Pozn). 2012;16(3):223-9. doi: 10.5114/wo.2012.29289. Epub 2012 Jul 6.

48.

Novel broad-host-range vehicles for cloning and shuffling of gene cassettes.

Bartosik AA, Markowska A, Szarlak J, Kulińska A, Jagura-Burdzy G.

J Microbiol Methods. 2012 Jan;88(1):53-62. doi: 10.1016/j.mimet.2011.10.011. Epub 2011 Oct 26.

PMID:
22056795
49.

The effect of ε-aminocaproyl-S-benzyl-L-cysteine on the t-PA activity of human saliva.

Midura-Nowaczek K, Kaczyńska J, Bruzgo I, Markowska A, Drozdowska D.

Adv Med Sci. 2011;56(2):323-6. doi: 10.2478/v10039-011-0039-6.

PMID:
22037173
50.

Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells.

Markowska AI, Jefferies KC, Panjwani N.

J Biol Chem. 2011 Aug 26;286(34):29913-21. doi: 10.1074/jbc.M111.226423. Epub 2011 Jun 29.

Supplemental Content

Loading ...
Support Center